• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Computed Tomography coronary calcium scores may predict risk of cardiovascular events in cancer patients

byAlex Chan
January 11, 2024
in Cardiology, Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
Long-term outcomes for off-pump and on-pump CABG are similar
Share on FacebookShare on Twitter

1. Despite lower prevalence of traditional cardiovascular risk factors, cancer patients were observed to have similar cardiovascular disease (CVD) events ot non-cancer counterparts.

2. Coronary artery calcium score (CACS) were well correlated with CVD risk in cancer patients suggesting a potential role as a targeted screening tool. 

Evidence Level Rating: 2 (Good)

To date, cancer and cardiovascular disease (CVD) remain leading causes of mortality and morbidity worldwide. Recently, interaction between these two diseases have increasingly been recognized, as oncology patients face increased CVD risk even when lacking traditional risk factors. Less known however, is the efficacy of risk stratification scores such as CACS for assessing CVD risk and atherosclerosis in cancer patients. In this retrospective cohort study spanning five years, data from 10,742 patients, including 703 cancer (C) and 703 age- and sex-matched non-cancer (NC) individuals was utilized to fill this gap in literature. Patients had CACS scores, demographic data, and cardiovascular events investigated in the study. Despite lower prevalence of traditional risk factors, cancer patients exhibited comparable CVD events to non-cancer counterparts. CACS was higher in cancer patients, notably in the >400 category. Cancer patients with moderate (101–400) and extensive (>400) CACS showed increased prevalence of atherosclerotic burden, including peripheral arterial disease (PAD) and cerebrovascular accidents (CVA). Overall, the CACS scores along with the prevalence of CVD were similar when comparing cancer vs non-cancer patients involved in the cohort study. Study findings provide evidence that the use of traditional risk factors for CVD risk stratification of cancer patients. Instead, CACS may have a potential role as a targeted screening tool for cancer patients, and allow for early intervention. 

Click to read the study in Cardiooncology

Image: PD

RELATED REPORTS

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: cancercardiologycardiovascular diseasectMACEoncologyradiology
Previous Post

Radical cure with primaquine reduces risk of Plasmodium vivax parasitaemia in patients with Plasmodium falciparum infection

Next Post

High fruit intake was associated with lower incidence of type 2 diabetes

RelatedReports

A collection of symbolic items such as a microscope
Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026
Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
Next Post
Citrus consumption associated with malignant melanoma

High fruit intake was associated with lower incidence of type 2 diabetes

Spleen elastography may be effective in the diagnosis of portal hypertension

Deep learning algorithm enables accurate and fair prediction of post-liver transplant risk factors

#VisualAbstract: Delayed cord clamping reduces mortality in infants born pre-term

#VisualAbstract: Delayed cord clamping reduces mortality in infants born pre-term

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors
  • Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training
  • Prognostic associations of anthropometric indices vary by clinical outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.